About Khusheal Pharmaceuticals Private Limited
Data last updated:
Khusheal Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 16 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC288595.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹70,000. It is led by directors Yusuf Alimohammad Batawala and Tasnim Alimohammed Batawala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D/302 Shivalik Hermitage Chs Ltd Mahavishnu Mandir W/Ehighway Mira Gaotan Mira Rd E, Thane, Maharashtra, India – 401107.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.61 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹47,841 (net margin 29.7%) and EBITDA of ₹47,841 (EBITDA margin 29.7%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website khusheal.com.
Company details
Contact details
Khusheal Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is khusheal.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressD/302 Shivalik Hermitage Chs Ltd Mahavishnu Mandir W/Ehighway Mira Gaotan Mira Rd E, Thane, Maharashtra, India – 401107
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Khusheal Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Khusheal Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Khusheal Pharmaceuticals Private Limited, buy the company report.
Financials of Khusheal Pharmaceuticals Private Limited
FY 2025 filings availableKhusheal Pharmaceuticals Private Limited reported revenue of ₹1.61 Lakh (up 246% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over three years, including 246% growth in the latest year. EBITDA rose 155% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹47,841 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹47,841 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29.7% | ||||
| Net Profit Margin | 29.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Khusheal Pharmaceuticals Private Limited, buy the company report.
Board of directors of Khusheal Pharmaceuticals Private Limited
Khusheal Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yusuf Alimohammad Batawala Also directs: Hsny Global LLP, Funferry Solutions Private Limited, Finegame Solutions Private Limited and 1 more | Additional Director | 26 May 2025 | 1 Years 5 Months | Current |
| Tasnim Alimohammed Batawala | Additional Director | 26 May 2025 | 1 Years 5 Months | Current |
Peer comparison
Khusheal Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nicolette Pharmaceuticals Private Limited | ₹1.63 Lakh (FY 2024) | -22.0% | Mumbai, Maharashtra, India | |||
| Trustcure Pharmaceuticals Private Limited | ₹1.62 Lakh (FY 2018) | Anantnag, Jammu and Kashmir, India | ||||
| Khusheal Pharmaceuticals Private Limitedthis company | ₹1.61 Lakh (FY 2025) | ₹47,841 | 29.7% | 246.0% | Thane, Maharashtra, India | |
| Medleods Pharmaceuticals Private Limited | ₹1.6 Lakh (FY 2024) | -4.0% | Maharashtra, India | |||
| Paramba Pharmaceuticals Private Limited | ₹1.58 Lakh (FY 2024) | -8.0% | Bhardwaj Nagar, Mohan Eghu, Bihar, India | |||
| Epazote Pharmaceuticals Private Limited | ₹1.58 Lakh (FY 2022) | Ambala, Haryana, India |
To see the full peer comparison of Khusheal Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Khusheal Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Khusheal Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Khusheal Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Khusheal Pharmaceuticals Private Limited has 4 board changes on record since 2025: 2 appointments and 2 cessations. The latest: Nima Sandeepsingh Pawar ceased to be Director on 27 May 2025.
Frequently asked questions
Khusheal Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 16 December 2016 (10+ years old) and is registered under CIN U74999MH2016PTC288595.
Khusheal Pharmaceuticals has 2 current directors:
- Yusuf Alimohammad Batawala - Additional Director
- Tasnim Alimohammed Batawala - Additional Director
The latest financial statements of Khusheal Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Khusheal Pharmaceuticals is U74999MH2016PTC288595. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Khusheal Pharmaceuticals was incorporated on 16 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Khusheal Pharmaceuticals by revenue are Nicolette Pharmaceuticals Private Limited, Trustcure Pharmaceuticals Private Limited, Medleods Pharmaceuticals Private Limited, Paramba Pharmaceuticals Private Limited, Epazote Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Nima Sandeepsingh Pawar ceased to be Director on 27 May 2025. Pinakini Jaswant Tolat ceased to be Director on 27 May 2025. Tasnim Alimohammed Batawala was appointed as Additional Director on 26 May 2025. Khusheal Pharmaceuticals has 4 board changes on record in total.
Khusheal Pharmaceuticals can be reached through the website khusheal.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Khusheal Pharmaceuticals is at D302 Shivalik Hermitage Chs Ltd Mahavishnu Mandir WEhighway Mira Gaotan Mira Rd E, Thane, Maharashtra, India – 401107.
Khusheal Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Khusheal Pharmaceuticals is compliant as of 20 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
